These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 29338587

  • 1. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M, Natorska J, Undas A.
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [Abstract] [Full Text] [Related]

  • 2. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M, Celińska-Löwenhoff M, Plens K, Iwaniec T, Musiał J, Undas A.
    J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
    Zhang S, Wu Z, Zhang W, Zhao J, Norman GL, Zeng X, Zhang F, Li Y.
    Clin Chem Lab Med; 2018 May 24; 56(6):939-946. PubMed ID: 29561729
    [Abstract] [Full Text] [Related]

  • 4. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzato A, Pengo V, Punzi L.
    Lupus; 2012 Jun 24; 21(7):787-9. PubMed ID: 22635234
    [Abstract] [Full Text] [Related]

  • 5. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.
    Clin Chem Lab Med; 2015 Jul 24; 53(8):1265-70. PubMed ID: 25562605
    [Abstract] [Full Text] [Related]

  • 6. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
    Hoxha A, Mattia E, Tonello M, Grava C, Pengo V, Ruffatti A.
    Clin Chem Lab Med; 2017 May 01; 55(6):890-898. PubMed ID: 27816952
    [Abstract] [Full Text] [Related]

  • 7. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.
    Thromb Res; 2019 May 01; 177():157-160. PubMed ID: 30903876
    [Abstract] [Full Text] [Related]

  • 8. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.
    Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.
    Arthritis Care Res (Hoboken); 2018 Apr 01; 70(4):627-634. PubMed ID: 28686816
    [Abstract] [Full Text] [Related]

  • 9. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H, Zheng H, Yin YF, Hu QY, Teng JL, Sun Y, Liu HL, Cheng XB, Ye JN, Su YT, Wu XY, Zhou JF, Norman GL, Gong HY, Shi XM, Peng YB, Wang XF, Yang CD.
    Clin Chem Lab Med; 2018 Mar 28; 56(4):614-624. PubMed ID: 29166262
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG.
    Clin Rheumatol; 2017 Feb 28; 36(2):401-406. PubMed ID: 28050648
    [Abstract] [Full Text] [Related]

  • 11. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A, Chayoua W, de Laat B, Moore GW, Musiał J, Zuily S, Wahl D, Devreese KMJ.
    J Thromb Haemost; 2022 Sep 28; 20(9):2136-2150. PubMed ID: 35713971
    [Abstract] [Full Text] [Related]

  • 12. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N, Bentow C, Rubio L, Norman GL, López-Sañudo S, Mahler M, Pérez-Isidro A, Cervera R, Viñas O, Espinosa G, Ruiz-Ortiz E.
    Front Immunol; 2021 Sep 28; 12():754469. PubMed ID: 34790198
    [Abstract] [Full Text] [Related]

  • 13. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML.
    Thromb Haemost; 2014 Feb 28; 111(2):354-64. PubMed ID: 24172938
    [Abstract] [Full Text] [Related]

  • 14. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
    Vlagea A, Gil A, Cuesta MV, Arribas F, Diez J, Lavilla P, Pascual-Salcedo D.
    Clin Appl Thromb Hemost; 2013 Jun 28; 19(3):289-96. PubMed ID: 22387581
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
    Bertolaccini ML, Sciascia S, Murru V, Garcia-Fernandez C, Sanna G, Khamashta MA.
    Thromb Haemost; 2013 Feb 28; 109(2):207-13. PubMed ID: 23254928
    [Abstract] [Full Text] [Related]

  • 16. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.
    Clin Exp Immunol; 2015 May 28; 180(2):218-26. PubMed ID: 25522978
    [Abstract] [Full Text] [Related]

  • 17. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    Canti V, Del Rosso S, Tonello M, Lucianò R, Hoxha A, Coletto LA, Vaglio Tessitore I, Rosa S, Manfredi AA, Castiglioni MT, Ruffatti A, Rovere-Querini P.
    J Rheumatol; 2018 Aug 28; 45(9):1263-1272. PubMed ID: 30008452
    [Abstract] [Full Text] [Related]

  • 18. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A, Gris JC, Moore GW, Musiał J, Zuily S, Wahl D, Devreese KMJ.
    J Thromb Haemost; 2023 Jul 28; 21(7):1981-1994. PubMed ID: 37061133
    [Abstract] [Full Text] [Related]

  • 19. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies.
    Radin M, Barinotti A, Foddai SG, Cecchi I, Rubini E, Roccatello D, Menegatti E, Sciascia S.
    Immunol Res; 2021 Aug 28; 69(4):372-377. PubMed ID: 34245429
    [Abstract] [Full Text] [Related]

  • 20. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T.
    Arthritis Rheum; 2000 Sep 28; 43(9):1982-93. PubMed ID: 11014348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.